Early Stage Venture RayzeBio Raises Series A of $45000000

October 13, 2020

About RayzeBio

RayzeBio is focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes.

Website: Learn more on RayzeBio’s website

Crunchbase: Follow on Crunchbase

[adace-ad id=”4426″]

Series A – RayzeBio

Amount Raised45000000 USD
Announced Date2020-10-14
Equity Only FundingYes
Organization LocationSan Diego, California, United States, North America
Funding StatusEarly Stage Venture
Number of Funding Rounds1
Lead InvestorsvenBio Partners, Versant Ventures
Number of Investors3
Number of Partner Investors2